Headline
The latest stories from AHA Today.
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations.
The Centers for Medicare & Medicaid Services today issued a proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2020.
The AHA today voiced support for the Recovering Excessive Funds for Unused and Needless Drugs Act (S. 551), legislation that would incentivize manufacturers to align package sizes with common dosage amounts.
Critical Access Hospitals, certain clinics, and other eligible outpatient facilities that provide primary care or substance use disorder treatment to high-need urban or rural areas can apply through May 30 to become a National Health Service Corps site.
More than 9 in 10 hospitals used their electronic health record data to inform clinical practice in 2017.
The Food and Drug Administration today ordered manufacturers to immediately stop selling and distributing surgical mesh products for transvaginal repair of pelvic organ prolapse in the U.S.
Readmissions penalties for hospitals with the greatest share of dually eligible beneficiaries could fall by an estimated $22.4 million in fiscal year 2019, while penalties for hospitals with the least share of dually eligible patients could rise by $12.3 million.
The Centers for Medicare & Medicaid Services should evaluate state survey agency processes to ensure that all states are meeting federal requirements for investigating complaints and incidents alleging abuse in nursing homes.
The Food and Drug Administration Friday alerted hospitals and others to a temporary shortage of a tracheostomy tube used to help adult and pediatric patients breathe in health care facilities and at home.
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation.